Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Substance related disorders are associated with impaired valuation of delayed gratification and feedback processing: A multilevel meta-analysis and meta-regression.

Kluwe-Schiavon B, Viola TW, Sanvicente-Vieira B, Lumertz FS, Salum GA, Grassi-Oliveira R, Quednow BB.

Neurosci Biobehav Rev. 2019 Nov 25;108:295-307. doi: 10.1016/j.neubiorev.2019.11.016. [Epub ahead of print] Review.

PMID:
31778679
2.

Threat Memory Reminder Under Matrix Metalloproteinase 9 Inhibitor Doxycycline Globally Reduces Subsequent Memory Plasticity.

Bach DR, Näf M, Deutschmann M, Tyagarajan SK, Quednow BB.

J Neurosci. 2019 Nov 20;39(47):9424-9434. doi: 10.1523/JNEUROSCI.1285-19.2019. Epub 2019 Oct 15.

3.

Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers.

Dornbierer DA, Boxler M, Voegel CD, Stucky B, Steuer AE, Binz TM, Baumgartner MR, Baur DM, Quednow BB, Kraemer T, Seifritz E, Landolt HP, Bosch OG.

Int J Neuropsychopharmacol. 2019 Oct 1;22(10):631-639. doi: 10.1093/ijnp/pyz047.

4.

Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders.

Liu Y, van den Wildenberg WPM, de Graaf Y, Ames SL, Baldacchino A, Bø R, Cadaveira F, Campanella S, Christiansen P, Claus ED, Colzato LS, Filbey FM, Foxe JJ, Garavan H, Hendershot CS, Hester R, Jester JM, Karoly HC, Kräplin A, Kreusch F, Landrø NI, Littel M, Loeber S, London ED, López-Caneda E, Lubman DI, Luijten M, Marczinski CA, Metrik J, Montgomery C, Papachristou H, Mi Park S, Paz AL, Petit G, Prisciandaro JJ, Quednow BB, Ray LA, Roberts CA, Roberts GMP, de Ruiter MB, Rupp CI, Steele VR, Sun D, Takagi M, Tapert SF, van Holst RJ, Verdejo-Garcia A, Vonmoos M, Wojnar M, Yao Y, Yücel M, Zack M, Zucker RA, Huizenga HM, Wiers RW.

Neurosci Biobehav Rev. 2019 Oct;105:288-304. doi: 10.1016/j.neubiorev.2019.07.006. Epub 2019 Jul 15. Review.

5.

Web-based self-help with and without chat counseling to reduce cocaine use in cocaine misusers: Results of a three-arm randomized controlled trial.

Schaub MP, Castro RP, Wenger A, Baumgartner C, Stark L, Ebert DD, Quednow BB, Haug S.

Internet Interv. 2019 May 22;17:100251. doi: 10.1016/j.invent.2019.100251. eCollection 2019 Sep.

6.

Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.

Gastberger S, Baumgartner MR, Soyka M, Quednow BB, Hulka LM, Herdener M, Seifritz E, Mutschler J.

Eur Addict Res. 2019;25(4):207-212. doi: 10.1159/000500542. Epub 2019 May 8.

PMID:
31067528
7.

Improvement of Emotional Empathy and Cluster B Personality Disorder Symptoms Associated With Decreased Cocaine Use Severity.

Vonmoos M, Eisenegger C, Bosch OG, Preller KH, Hulka LM, Baumgartner M, Seifritz E, Quednow BB.

Front Psychiatry. 2019 Apr 5;10:213. doi: 10.3389/fpsyt.2019.00213. eCollection 2019.

8.

Neurophysiological signature of gamma-hydroxybutyrate augmented sleep in male healthy volunteers may reflect biomimetic sleep enhancement: a randomized controlled trial.

Dornbierer DA, Baur DM, Stucky B, Quednow BB, Kraemer T, Seifritz E, Bosch OG, Landolt HP.

Neuropsychopharmacology. 2019 Oct;44(11):1985-1993. doi: 10.1038/s41386-019-0382-z. Epub 2019 Apr 8.

PMID:
30959514
9.

Cocaine Hydroxy Metabolites in Hair: Indicators for Cocaine Use Versus External Contamination☆.

Scholz C, Quednow BB, Herdener M, Kraemer T, Baumgartner MR.

J Anal Toxicol. 2019 Aug 23;43(7):543-552. doi: 10.1093/jat/bkz022.

PMID:
30927360
10.

Effects of gamma-hydroxybutyrate on neurophysiological correlates of performance and conflict monitoring.

Dornbierer DA, Kometer M, Von Rotz R, Studerus E, Gertsch J, Gachet MS, Vollenweider FX, Seifritz E, Bosch OG, Quednow BB.

Eur Neuropsychopharmacol. 2019 Apr;29(4):539-548. doi: 10.1016/j.euroneuro.2019.02.004. Epub 2019 Feb 26.

PMID:
30824339
11.

Longitudinal changes in cocaine intake and cognition are linked to cortical thickness adaptations in cocaine users.

Hirsiger S, Hänggi J, Germann J, Vonmoos M, Preller KH, Engeli EJE, Kirschner M, Reinhard C, Hulka LM, Baumgartner MR, Chakravarty MM, Seifritz E, Herdener M, Quednow BB.

Neuroimage Clin. 2019;21:101652. doi: 10.1016/j.nicl.2019.101652. Epub 2019 Jan 4.

12.

Non-medical prescription opioid users exhibit dysfunctional physiological stress responses to social rejection.

Kroll SL, Williams DP, Thoma M, Staib M, Binz TM, Baumgartner MR, Kirschbaum C, Thayer JF, Quednow BB.

Psychoneuroendocrinology. 2019 Feb;100:264-275. doi: 10.1016/j.psyneuen.2018.09.023. Epub 2018 Sep 19.

PMID:
30594739
13.

Identification of new urinary gamma-hydroxybutyric acid markers applying untargeted metabolomics analysis following placebo-controlled administration to humans.

Steuer AE, Raeber J, Steuer C, Boxler MI, Dornbierer DA, Bosch OG, Quednow BB, Seifritz E, Kraemer T.

Drug Test Anal. 2019 Jun;11(6):813-823. doi: 10.1002/dta.2558. Epub 2019 Jan 16.

PMID:
30548573
14.

Prohedonic properties of gamma-hydroxybutyrate are associated with changes in limbic resting-state functional connectivity.

Bosch OG, Esposito F, Dornbierer D, von Rotz R, Kraehenmann R, Staempfli P, Quednow BB, Seifritz E.

Hum Psychopharmacol. 2018 Nov;33(6):e2679. doi: 10.1002/hup.2679. Epub 2018 Nov 13.

PMID:
30426556
15.

Self-regulation of the dopaminergic reward circuit in cocaine users with mental imagery and neurofeedback.

Kirschner M, Sladky R, Haugg A, Stämpfli P, Jehli E, Hodel M, Engeli E, Hösli S, Baumgartner MR, Sulzer J, Huys QJM, Seifritz E, Quednow BB, Scharnowski F, Herdener M.

EBioMedicine. 2018 Nov;37:489-498. doi: 10.1016/j.ebiom.2018.10.052. Epub 2018 Oct 28.

16.

Cognitive and neuroanatomical impairments associated with chronic exposure to levamisole-contaminated cocaine.

Vonmoos M, Hirsiger S, Preller KH, Hulka LM, Allemann D, Herdener M, Baumgartner MR, Quednow BB.

Transl Psychiatry. 2018 Oct 27;8(1):235. doi: 10.1038/s41398-018-0279-3.

17.

Frontostriatal pathways gate processing of behaviorally relevant reward dimensions.

Weber SC, Kahnt T, Quednow BB, Tobler PN.

PLoS Biol. 2018 Oct 19;16(10):e2005722. doi: 10.1371/journal.pbio.2005722. eCollection 2018 Oct.

18.

Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users.

Kroll SL, Nikolic E, Bieri F, Soyka M, Baumgartner MR, Quednow BB.

Psychopharmacology (Berl). 2018 Dec;235(12):3451-3464. doi: 10.1007/s00213-018-5060-z. Epub 2018 Oct 11.

PMID:
30310961
19.

Socio-cognitive functioning in stimulant polysubstance users.

Kroll SL, Wunderli MD, Vonmoos M, Hulka LM, Preller KH, Bosch OG, Baumgartner MR, Quednow BB.

Drug Alcohol Depend. 2018 Sep 1;190:94-103. doi: 10.1016/j.drugalcdep.2018.06.001. Epub 2018 Jun 30.

PMID:
30005311
20.

Glucocorticoid receptor gene variants and lower expression of NR3C1 are associated with cocaine use.

Schote AB, Jäger K, Kroll SL, Vonmoos M, Hulka LM, Preller KH, Meyer J, Grünblatt E, Quednow BB.

Addict Biol. 2019 Jul;24(4):730-742. doi: 10.1111/adb.12632. Epub 2018 May 15.

PMID:
29761890
21.

Gamma-hydroxybutyrate increases brain resting-state functional connectivity of the salience network and dorsal nexus in humans.

Bosch OG, Esposito F, Dornbierer D, Havranek MM, von Rotz R, Kometer M, Staempfli P, Quednow BB, Seifritz E.

Neuroimage. 2018 Jun;173:448-459. doi: 10.1016/j.neuroimage.2018.03.011. Epub 2018 Mar 7.

PMID:
29524621
22.
23.

Endogenous cortisol in keratinized matrices: Systematic determination of baseline cortisol levels in hair and the influence of sex, age and hair color.

Binz TM, Rietschel L, Streit F, Hofmann M, Gehrke J, Herdener M, Quednow BB, Martin NG, Rietschel M, Kraemer T, Baumgartner MR.

Forensic Sci Int. 2018 Mar;284:33-38. doi: 10.1016/j.forsciint.2017.12.032. Epub 2017 Dec 24.

PMID:
29331681
24.

Meta-analysis on the association between genetic polymorphisms and prepulse inhibition of the acoustic startle response.

Quednow BB, Ejebe K, Wagner M, Giakoumaki SG, Bitsios P, Kumari V, Roussos P.

Schizophr Res. 2018 Aug;198:52-59. doi: 10.1016/j.schres.2017.12.011. Epub 2017 Dec 26. Review.

PMID:
29287625
25.

Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy").

Wunderli MD, Vonmoos M, Treichler L, Zeller C, Dziobek I, Kraemer T, Baumgartner MR, Seifritz E, Quednow BB.

Int J Neuropsychopharmacol. 2018 Apr 1;21(4):333-344. doi: 10.1093/ijnp/pyx098.

26.

Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.

Hassan Z, Bosch OG, Singh D, Narayanan S, Kasinather BV, Seifritz E, Kornhuber J, Quednow BB, Müller CP.

Front Psychiatry. 2017 Aug 18;8:152. doi: 10.3389/fpsyt.2017.00152. eCollection 2017. Review.

27.

Discrete memory impairments in largely pure chronic users of MDMA.

Wunderli MD, Vonmoos M, Fürst M, Schädelin K, Kraemer T, Baumgartner MR, Seifritz E, Quednow BB.

Eur Neuropsychopharmacol. 2017 Oct;27(10):987-999. doi: 10.1016/j.euroneuro.2017.08.425. Epub 2017 Aug 31.

28.

MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent 'Ecstasy' users.

Roberts CA, Quednow BB, Montgomery C, Parrott AC.

Neurosci Biobehav Rev. 2018 Jan;84:470-482. doi: 10.1016/j.neubiorev.2017.07.015. Epub 2017 Aug 8. Review.

29.

Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans.

Bosch OG, Esposito F, Havranek MM, Dornbierer D, von Rotz R, Staempfli P, Quednow BB, Seifritz E.

Neuropsychopharmacology. 2017 Oct;42(11):2141-2151. doi: 10.1038/npp.2017.110. Epub 2017 May 31.

30.

Neuronal oscillations and synchronicity associated with gamma-hydroxybutyrate during resting-state in healthy male volunteers.

von Rotz R, Kometer M, Dornbierer D, Gertsch J, Salomé Gachet M, Vollenweider FX, Seifritz E, Bosch OG, Quednow BB.

Psychopharmacology (Berl). 2017 Jul;234(13):1957-1968. doi: 10.1007/s00213-017-4603-z. Epub 2017 Apr 20.

31.

Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humans.

Bosch OG, Havranek MM, Baumberger A, Preller KH, von Rotz R, Herdener M, Kraehenmann R, Staempfli P, Scheidegger M, Klucken T, Seifritz E, Quednow BB.

Eur Neuropsychopharmacol. 2017 Apr;27(4):372-382. doi: 10.1016/j.euroneuro.2017.02.006. Epub 2017 Mar 8.

32.

Stable self-serving personality traits in recreational and dependent cocaine users.

Quednow BB, Hulka LM, Preller KH, Baumgartner MR, Eisenegger C, Vonmoos M.

PLoS One. 2017 Mar 2;12(3):e0172853. doi: 10.1371/journal.pone.0172853. eCollection 2017.

33.

Pregabalin Use Among Opioid-Addicted Patients in Switzerland.

Mutschler J, Gastberger S, Baumgartner MR, Grosshans M, Seifritz E, Quednow BB, Herdener M.

J Clin Psychiatry. 2016 Sep;77(9):1202-1203. doi: 10.4088/JCP.15l10296. No abstract available.

34.

Modeling startle eyeblink electromyogram to assess fear learning.

Khemka S, Tzovara A, Gerster S, Quednow BB, Bach DR.

Psychophysiology. 2017 Feb;54(2):204-214. doi: 10.1111/psyp.12775. Epub 2016 Oct 18.

35.

Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans.

Weber SC, Beck-Schimmer B, Kajdi ME, Müller D, Tobler PN, Quednow BB.

Transl Psychiatry. 2016 Jul 5;6(7):e850. doi: 10.1038/tp.2016.113.

36.

Risky Decisions in a Lottery Task Are Associated with an Increase of Cocaine Use.

Wittwer A, Hulka LM, Heinimann HR, Vonmoos M, Quednow BB.

Front Psychol. 2016 May 9;7:640. doi: 10.3389/fpsyg.2016.00640. eCollection 2016.

37.

Cognitive and emotional impairments in adults with attention-deficit/hyperactivity disorder and cocaine use.

Wunderli MD, Vonmoos M, Niedecker SM, Hulka LM, Preller KH, Baumgartner MR, Kraemer T, Seifritz E, Schaub MP, Eich-Höchli D, Quednow BB.

Drug Alcohol Depend. 2016 Jun 1;163:92-9. doi: 10.1016/j.drugalcdep.2016.03.026. Epub 2016 Apr 7.

PMID:
27085500
38.

Shared neural basis of social and non-social reward deficits in chronic cocaine users.

Tobler PN, Preller KH, Campbell-Meiklejohn DK, Kirschner M, Kraehenmann R, Stämpfli P, Herdener M, Seifritz E, Quednow BB.

Soc Cogn Affect Neurosci. 2016 Jun;11(6):1017-25. doi: 10.1093/scan/nsw030. Epub 2016 Mar 12.

39.

Human pharmacology for addiction medicine: From evidence to clinical recommendations.

Quednow BB, Herdener M.

Prog Brain Res. 2016;224:227-50. doi: 10.1016/bs.pbr.2015.07.017. Epub 2015 Oct 27.

PMID:
26822361
40.

CaM Kinases: From Memories to Addiction.

Müller CP, Quednow BB, Lourdusamy A, Kornhuber J, Schumann G, Giese KP.

Trends Pharmacol Sci. 2016 Feb;37(2):153-166. doi: 10.1016/j.tips.2015.11.001. Epub 2015 Dec 7. Review.

41.

Uncontrollable and unpredictable stress interacts with subclinical depression and anxiety scores in determining anxiety response.

Havranek MM, Bolliger B, Roos S, Pryce CR, Quednow BB, Seifritz E.

Stress. 2016;19(1):53-62. doi: 10.3109/10253890.2015.1117449. Epub 2015 Dec 15.

42.

Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.

Liechti ME, Quednow BB, Liakoni E, Dornbierer D, von Rotz R, Gachet MS, Gertsch J, Seifritz E, Bosch OG.

Br J Clin Pharmacol. 2016 May;81(5):980-8. doi: 10.1111/bcp.12863. Epub 2016 Feb 25.

43.

α2A -Adrenergic receptor polymorphisms and mRNA expression levels are associated with delay discounting in cocaine users.

Havranek MM, Hulka LM, Tasiudi E, Eisenegger C, Vonmoos M, Preller KH, Mössner R, Baumgartner MR, Seifritz E, Grünblatt E, Quednow BB.

Addict Biol. 2017 Mar;22(2):561-569. doi: 10.1111/adb.12324. Epub 2015 Nov 8.

44.

Amygdala response to self-critical stimuli and symptom improvement in psychotherapy for depression.

Doerig N, Krieger T, Altenstein D, Schlumpf Y, Spinelli S, Späti J, Brakowski J, Quednow BB, Seifritz E, Holtforth MG.

Br J Psychiatry. 2016 Feb;208(2):175-81. doi: 10.1192/bjp.bp.114.149971. Epub 2015 Oct 22.

PMID:
26494872
45.

Erratum to: Evaluating the efficacy of a web-based self-help intervention with and without chat counseling in reducing the cocaine use of problematic cocaine users: the study protocol of a pragmatic three-arm randomized controlled trial.

Schaub MP, Maier LJ, Wenger A, Stark L, Berg O, Beck T, Quednow BB, Haug S.

BMC Psychiatry. 2015 Sep 16;15:218. doi: 10.1186/s12888-015-0600-0. No abstract available.

46.

Gamma-hydroxybutyrate enhances mood and prosocial behavior without affecting plasma oxytocin and testosterone.

Bosch OG, Eisenegger C, Gertsch J, von Rotz R, Dornbierer D, Gachet MS, Heinrichs M, Wetter TC, Seifritz E, Quednow BB.

Psychoneuroendocrinology. 2015 Dec;62:1-10. doi: 10.1016/j.psyneuen.2015.07.167. Epub 2015 Jul 17.

47.
48.

Pharmacological Cognitive Enhancement in Healthy Individuals: A Compensation for Cognitive Deficits or a Question of Personality?

Maier LJ, Wunderli MD, Vonmoos M, Römmelt AT, Baumgartner MR, Seifritz E, Schaub MP, Quednow BB.

PLoS One. 2015 Jun 24;10(6):e0129805. doi: 10.1371/journal.pone.0129805. eCollection 2015.

49.

Changes in cocaine consumption are associated with fluctuations in self-reported impulsivity and gambling decision-making.

Hulka LM, Vonmoos M, Preller KH, Baumgartner MR, Seifritz E, Gamma A, Quednow BB.

Psychol Med. 2015 Oct;45(14):3097-110. doi: 10.1017/S0033291715001063. Epub 2015 Jun 17.

PMID:
26081043
50.

Serotonin Transporter and Tryptophan Hydroxylase Gene Variations Mediate Working Memory Deficits of Cocaine Users.

Havranek MM, Vonmoos M, Müller CP, Büetiger JR, Tasiudi E, Hulka LM, Preller KH, Mössner R, Grünblatt E, Seifritz E, Quednow BB.

Neuropsychopharmacology. 2015 Dec;40(13):2929-37. doi: 10.1038/npp.2015.146. Epub 2015 May 27.

Supplemental Content

Loading ...
Support Center